184 related articles for article (PubMed ID: 32600864)
21. Analysis of the risk factors of linezolid-related haematological toxicity in Chinese patients.
Dai Y; Jiang S; Chen X; Han L; Zhang C; Yu X; Zhang X
J Clin Pharm Ther; 2021 Jun; 46(3):807-813. PubMed ID: 33555057
[TBL] [Abstract][Full Text] [Related]
22. Linezolid-induced lactic acidosis.
Ramesh V; Gattu S; Maqsood M; Rao V
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38331448
[TBL] [Abstract][Full Text] [Related]
23. Risk factor analysis for linezolid-associated thrombocytopenia in critically ill patients.
Cazavet J; Bounes FV; Ruiz S; Seguin T; Crognier L; Rouget A; Fourcade O; Minville V; Conil JM; Georges B
Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):527-538. PubMed ID: 31853741
[TBL] [Abstract][Full Text] [Related]
24. Lactic Acidosis and Thrombocytopenia Associated with Linezolid Therapy: A Case Report.
Xiao B; Deng P; Jin H; Wang H; Cao Y
Am J Case Rep; 2018 Sep; 19():1117-1120. PubMed ID: 30232318
[TBL] [Abstract][Full Text] [Related]
25. Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers.
Thirot H; Fage D; Leonhardt A; Clevenbergh P; Besse-Hammer T; Yombi JC; Cornu O; Briquet C; Hites M; Jacobs F; Wijnant GJ; Wicha SG; Cotton F; Tulkens PM; Spinewine A; Van Bambeke F
Front Pharmacol; 2024; 15():1310309. PubMed ID: 38313312
[No Abstract] [Full Text] [Related]
26. Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients.
Kawasuji H; Tsuji Y; Ogami C; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y
Antibiotics (Basel); 2021 Apr; 10(5):. PubMed ID: 33925912
[TBL] [Abstract][Full Text] [Related]
27. Linezolid-Induced Thrombocytopenia in Patients with Renal Impairment: A Case Series, Review and Dose Advice.
Laarhuis SRE; Kerskes CHM; Nijziel MR; van Wensen RJA; Touw DJ
Drugs R D; 2024 Mar; 24(1):109-115. PubMed ID: 38480595
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the impact of rifampicin on the plasma concentration of linezolid in tuberculosis co-infected patients.
Yan P; Shi QZ; Hu YX; Zeng Y; Lu H
Front Pharmacol; 2023; 14():1260535. PubMed ID: 38026932
[TBL] [Abstract][Full Text] [Related]
29. Severe linezolid-induced lactic acidosis in a child with acute lymphoblastic leukemia: A case report.
Smolka V; Rohanova M; Ludikova B; Novak Z; Zapalka M; Pospisilova D; Volejnikova J
J Infect Chemother; 2020 Dec; 26(12):1316-1318. PubMed ID: 32859497
[TBL] [Abstract][Full Text] [Related]
30. Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study.
Kim HS; Lee E; Cho YJ; Lee YJ; Rhie SJ
J Clin Pharm Ther; 2019 Feb; 44(1):84-90. PubMed ID: 30243033
[TBL] [Abstract][Full Text] [Related]
31. Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections.
Cattaneo D; Orlando G; Cozzi V; Cordier L; Baldelli S; Merli S; Fucile S; Gulisano C; Rizzardini G; Clementi E
Int J Antimicrob Agents; 2013 Jun; 41(6):586-9. PubMed ID: 23562639
[TBL] [Abstract][Full Text] [Related]
32. Population Pharmacokinetics of Intravenous Linezolid in Premature Infants.
Thibault C; Kassir N; Goyer I; Théorêt Y; Litalien C; Moussa A; Ovetchkine P; Autmizguine J
Pediatr Infect Dis J; 2019 Jan; 38(1):82-88. PubMed ID: 29634620
[TBL] [Abstract][Full Text] [Related]
33. Linezolid Dosing in Patients With Liver Cirrhosis: Standard Dosing Risk Toxicity.
Luque S; Muñoz-Bermudez R; Echeverría-Esnal D; Sorli L; Campillo N; Martínez-Casanova J; González-Colominas E; Álvarez-Lerma F; Horcajada JP; Grau S; Roberts JA
Ther Drug Monit; 2019 Dec; 41(6):732-739. PubMed ID: 31259884
[TBL] [Abstract][Full Text] [Related]
34. A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?
Pea F; Cojutti P; Dose L; Baraldo M
Br J Clin Pharmacol; 2016 Feb; 81(2):341-8. PubMed ID: 26469887
[TBL] [Abstract][Full Text] [Related]
35. Does the conventional dosage of linezolid necessitate therapeutic drug monitoring?-Experience from a prospective observational study.
Fang J; Chen C; Wu Y; Zhang M; Zhang Y; Shi G; Yao Y; Chen H; Bian X
Ann Transl Med; 2020 Apr; 8(7):493. PubMed ID: 32395537
[TBL] [Abstract][Full Text] [Related]
36. Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration.
De Pascale G; Fortuna S; Tumbarello M; Cutuli SL; Vallecoccia M; Spanu T; Bello G; Montini L; Pennisi MA; Navarra P; Antonelli M
Intensive Care Med; 2015 Jan; 41(1):103-10. PubMed ID: 25413377
[TBL] [Abstract][Full Text] [Related]
37. Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients: A Call for Action?
Cattaneo D; Fusi M; Cozzi V; Baldelli S; Bonini I; Gervasoni C; Clementi E
Clin Pharmacokinet; 2021 May; 60(5):603-609. PubMed ID: 33180272
[TBL] [Abstract][Full Text] [Related]
38. Hematological toxicities associated with linezolid therapy in adults: key findings and clinical considerations.
Cattaneo D; Marriott DJ; Gervasoni C
Expert Rev Clin Pharmacol; 2023 Mar; 16(3):219-230. PubMed ID: 36787631
[TBL] [Abstract][Full Text] [Related]
39. Incidence and risk factors of linezolid-induced lactic acidosis.
Im JH; Baek JH; Kwon HY; Lee JS
Int J Infect Dis; 2015 Feb; 31():47-52. PubMed ID: 25499040
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic drug management of linezolid: a missed opportunity for clinicians?
Cattaneo D; Gervasoni C; Cozzi V; Castoldi S; Baldelli S; Clementi E
Int J Antimicrob Agents; 2016 Dec; 48(6):728-731. PubMed ID: 27769709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
